Specificity of xenoreactive anti-Galα1–3Gal IgM for α-galactosyl ligands

By Parker William   Lateef Jarama   Everett Mary Lou   Platt Jeffrey L.  

Glycobiology, Vol. 6, Iss. 5, 1996-07 ,pp. : 499-506

Oxford University Press

Access to resources Recommend Favorite

Molecular mimicry in the recognition of glycosphingolipids by Galα3Galβ4GlcNAcβ-binding Clostridium difficile toxin A, human natural anti α-galactosyl IgG and the monoclonal antibody Gal-13: characterization of a binding-active human glycosphingolipid, non-identical with the animal receptor

By Teneberg Susann   Lönnroth Ivar  

Glycobiology, Vol. 6, Iss. 6, 1996-09 ,pp. : 599-609

Oxford University Press

Access to resources Recommend Favorite

Alpha-Galactosyl trisaccharide epitope: Modification of the 6-primary positions and recognition by human anti-αGal antibody

By Andreana Peter R.   Kowal Przemyslaw   Janczuk Adam J.   Wang Peng George  

Glycoconjugate Journal, Vol. 20, Iss. 2, 2003-01 ,pp. : 107-118

Springer Publishing Company

Access to resources Recommend Favorite

Differential expression of Galα1,3Gal epitope in polymeric and monomeric IgM secreted by mouse myeloma cells deficient in α2,6-sialyltransferase

By Fagioli C.  

Glycobiology, Vol. 8, Iss. 8, 1998-07 ,pp. : 841-848

Oxford University Press

Access to resources Recommend Favorite

Synthesis and characterization of a novel glycopolymer with protective activity toward human anti-α-Gal antibodies

By Vetere A.   Donati I.   Campa C.   Semeraro S.   Gamini A.   Paoletti S.  

Glycobiology, Vol. 12, Iss. 4, 2002-04 ,pp. : 283-290

Oxford University Press

Access to resources Recommend Favorite